Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 91396-88-2 | Product Number: I0975
PluriSIn 1
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 4-Pyridinecarboxylic Acid 2-Phenylhydrazide
- Isonicotinic Acid 2-Phenylhydrazide
- NSC 14613
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 20MG |
€58.00
|
2 | 4 |
|
| 100MG |
€203.00
|
1 | 13 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | I0975 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__2H__1__1N__3O = 213.24 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 91396-88-2 |
| Reaxys Registry Number | 172867 |
| PubChem Substance ID | 354333242 |
| MDL Number | MFCD02344904 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 18.70 to 20.70 % |
| Melting point | 186.0 to 190.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 189 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
Transport Information:
| HS Number | 2933399990 |
Application
Stearoyl-CoA Desaturase Inhibitor
References
- 1)Establishment in culture of pluripotential cells from mouse embryos
- 2)Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
- 3)Induction of pluripotent stem cells from adult human fibroblasts by defined factors
- 4)Adaptation to culture of human embryonic stem cells and oncogenesis in vivo
- 5)The tumorigenicity of human embryonic and induced pluripotent stem cells
- 6)Variation in the safety of induced pluripotent stem cell lines
- 7) Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection
- 8)Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.